Introducing Richard Tame, a seasoned executive currently serving as CFO at Coeus Institute. His journey across various industries and renowned corporations has been nothing short of remarkable. From his early days at British Airways to his stints at tech giants like Amazon, Meta, and Lyft, Richard's career has been marked by a wealth of diverse experiences.

Jackson Moses is a successful serial entrepreneur and early defense tech investor. He currently serves as the Founder and Managing Partner of Silent Ventures, an early stage venture firm that invests in aerospace, defense, and national security startups including Andruil, Hadrian, Axiom Space, and Voyager Space.

Dr. Seth Lederman, CEO and Chairman of Tonix Pharmaceuticals, shares insights into his journey from medical practice to pharmaceutical entrepreneurship. From his early days combating the AIDS epidemic to specializing in rheumatology and fibromyalgia research, Dr. Lederman discusses the lessons learned from founding and leading Tonix Pharmaceuticals.

Jeff Hart is a partner at AE Industrial Partners, a Private Equity firm with over $6 Billion in AUM that has invested in some of the most exciting aerospace, security, and industrial companies across the country including Firefly Aerospace, Sierra Space, and York Space Systems.

Introducing Justus Kilian, Managing Partner at Space Capital, a venture firm at the forefront of the Tech-Space intersection, boasting a robust portfolio with over $100 million in assets under management. With a steadfast commitment to innovation, Space Capital has joined forces with visionary founders and made strategic investments in break out companies like Rocket Lab and SpaceX.

Meagan Murphy Crawford, Co-Founder and Managing Partner of SpaceFund, which has invested in over 20 aerospace companies including SpaceX, Axiom Space, and Voyager Space.

Andrea Hippeau is a Partner at Lerer Hippeau, an early-stage venture capital fund that has invested in some of the most forward thinking brands - Warby Parker, Allbirds, Cotopaxi, Casper, and Thrive.

Hadi Chaudhry is the CEO & President at CareCloud, a publicly traded healthcare technology company. Hadi was an early employee at CareCloud where he rose the ranks helping take the company public and eventually becoming CEO. He has over 20 years of experience in the industry, and has been at the forefront of driving innovation and efficiency in healthcare management.

Matthew Price, COO of Promontory Therapeutics is an experienced biotech entrepreneur / C-level executive, and the only company co-founder named a 2022 Emerging Pharma Leader by Pharmaceutical Executive. He is responsible for industry collaborations with Pfizer and Merck KGaA, and for Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute.

Shannon Erley, Founder & CEO of Pomp a groundbreaking platform connecting estheticians with their clients through technology in the beauty industry. .

Erik Mitisek, Co-Founder & President of Highwing, the first open data platform for commercial insurance. Highwing spun out of IMA Financial Group with a $4M seed round led by BRP Group and BrokerTech Ventures.

Joanna Arras joined Baird Capital in 2014, a venture capital investor focused on early- and expansion-stage companies that leverage technology to solve business problems or just make life easier. She is also currently a board member of ChurnZero, Circonus, FullContact, and SourceDay and was previously a board member of Appcast, Startwire, and Autobooks.

Jennifer Henderson is the Founder and CEO of Tilt, a venture backed SaaS platform that redefines the employee leave experience. Based on her own experience of leave being a career killer, Jennifer decided to change that narrative and create a platform that allows employees to take the necessary time for when life happens. Prior to founding Tilt, Jennifer was the Director of Operations at Noodles & Company and is a Board Member for CSU’s College of Business, Institute for Entrepreneurship.

Robert Jacks, has 20 years of experience in the biopharmaceutical industry. He has founded or co-founded multiple companies and raised more than $170 million with several successful exits.

Dr. Marcelo Bigal, President and CEO of Ventus Therapeutics, a company that expects to become the leader in the field of using precision medicine to identify subsets of patients with severe chronic neurological conditions.

Monica Palko, Chief Legal & Administrative Officer of York Space Systems in Denver, Colorado. She provides strategic and operational guidance within the C-Suite, with responsibilities that include government and commercial contracting, legal and compliance, and corporate governance.

Kelly Hennig, Chief Operating Officer of Stoke Space, one of the fastest growing aerospace companies developing reusable rockets to provide the satellite industry with low-cost, on-demand access to and from any orbit. Stoke’s investors include NFX, MaC Ventures, YC, Seven Seven Six Ventures, and several others.

Molly Harper, Chief Business Officer of Synlogic, a biotechnology company that went public in 2017 through a reverse merger with Mirna Therapeutics raising an additional $40M after $100M in venture capital funding. Molly is also a member of the Board of Directors for Catalyst Pharmaceuticals and PreciseDX. Molly attended Wharton for her MBA, Healthcare Management, and Bachelor of Arts from Cornell University.

Vlad Vitoc is the Founder & CEO of MAIA, an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Vlad and his team took MAIA public successfully in 2022 in one of the most difficult IPO markets in recent years.

Hans Keirstead, is a serial entrepreneur and currently the Founder, CEO and Chairman of Aivita Biomedical, a biotechnology company developing personalized vaccines for the prevention of infectious disease and treatment of cancer. He has now founded four biotechnology companies with successful exits in his previous three companies. Dr. Keirstead also holds Board positions in several prominent biotechnology companies.